FAQs

The CAR-TCR Summit is the world’s definitive, industry led cell therapy conference, taking place September 15 – 17 in Boston. The agenda features:

• 75+ expert speakers from every pocket of the cell therapy ecosystem
• All stages of pipeline development from translation through to commercialization
• 7 cell types including T, NK, macrophage, gamma delta, and TILs
• Both oncological and autoimmune indications
• 4 focus days, dedicated to fundamentals, in vivo, automated manufacturing, and regulatory, investment and pharma partnering

You can find your complete guide to the meeting here.

The CAR‑TCR Summit is a specialist cell therapy conference focused on CAR‑T, TCR, and engineered T‑cell development across the full lifecycle, from discovery and translation through clinical, manufacturing, and commercialization, delivering depth and technical relevance for senior decision makers.

You can find your complete guide to the meeting here.

The Summit is designed for senior leaders across biopharma, biotech, academia, investment, and specialist service providers actively advancing cell therapy and advanced therapy programs, with a strong concentration of teams developing CAR‑T, TCR, and next‑generation gene‑modified cell therapies.

Attendee breakdown is available in the full event guide.

Unlike large, generalist cell therapy conferences, the CAR‑TCR Summit prioritizes focused discussion, senior participation, and functional depth. The model supports meaningful engagement around real scientific, clinical, manufacturing, and commercial challenges facing CAR‑T and TCR programs today.

See the full agenda here.

The agenda spans dedicated tracks across discovery and translational science, clinical development and trial design, CMC and cell therapy manufacturing, analytical development, and commercial strategy, ensuring end‑to‑end relevance across CAR‑T, TCR, and advanced cell therapy pipelines.

See full session breakdowns in the event guide.

Yes. The program includes investor panels, pharma and investor roundtables, and structured 1:1 meetings designed to support informed investment discussions, strategic alignment, and partnering across CAR‑T, TCR, and broader cell therapy asset development.

The Summit offers over 14 hours of curated networking, including pre‑scheduled 1:1 meetings, focused roundtables, and dedicated receptions, enabling senior‑level engagement across the CAR‑T, TCR, and wider cell therapy ecosystem.

Partnership opportunities are selectively structured to prioritize qualified engagement with senior decision makers across cell therapy development, manufacturing, and commercialization, supporting high‑value conversations rather than high‑volume, trade‑show‑style exposure.

Find out more.

Are there any discounts available?

Group discounts are available, with up to 20% off when registering 4 or more attendees from the same company.

Full T&Cs are available here.

For inquiries regarding registration, speaking, or press, contact info@hansonwade.com. For sponsorship inquiries, please contact sponsor@hansonwade.com